Biomarker Testing in Alzheimer’s Disease

IE users – if you are experiencing issues trying to register for this webinar, please use Chrome, Safari or Firefox.

Wednesday, September 29, 2021
12:00 PM ET/9:00 AM PT

At the conclusion of this program, participants will be able to:
Describe Alzheimer's pathogenesis and the beta amyloid hypothesis
Discuss AT(N) biomarker categories and how they are used in Alzheimer's diagnosis
Describe differences between biomarkers and PET imaging in Alzheimer's disease
Discuss potential use of plasma amyloid β 42/40 in Alzheimer's disease
Michael K. Racke, MD
Medical Director, Neurology
Quest Diagnostics
Gabriele Olla
Director, Product Management, Neurology, Quest Diagnostics

INVITATION - Download printable invitation PDF